# OnCo record can-fite (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/can-fite/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "can-fite" ;
  schema:name "Can-Fite BioPharma"@en ;
  schema:alternateName "Can-Fite BioPharma Ltd"@en, "Can Fite Biopharma"@en ;
  schema:description "Can-Fite is an Israeli company developing adenosine A3 receptor agonists; namodenoson is in phase 3 as a second-line treatment for liver cancer in patients with poor liver function."@en ;
  schema:url <https://onco.cc/companies/can-fite/>, <https://www.canfite.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.canfite.com>, <https://clinicaltrials.gov/search?lead=Can-Fite%20BioPharma%20Ltd>, <https://www.wikidata.org/wiki/Q96482303> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "IL" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct06387342/>, <https://onco.cc/trials/nct05201404/> .